More Than

0

customers

In

0

Key Cities

across

0

Countries in Southeast Asia

corporate video

Click to watch corporate video.

Latest news

news

Interview with Lianhe Zaobao

We have been featured in Singapore’s Chinese newspaper, Lianhe Zaobao, on 22 November 2018.

English translation is available here. It is translated from the original article at https://www.sgsme.sg/cn/sme-interview/story20181122-14522, [“修读课程突破思维 业者自我创新“药”走向国际, Lianhe Zaobao, 22 November 2018”. Any errors are the translator’s own.]

Read more Read less
news

Hyphens Pharma and A*STAR Ink MoU to be Strategic Dialogue Partners in the Field of Dermatology

Hyphens Pharma and Agency for Science, Technology and Research (A*STAR) inked a memorandum of understanding (MoU) on becoming strategic dialogue partners to explore collaboration in market-relevant projects in dermatology research and skin disorders.

Hyphens is currently licensing sugar-based surfactant micro-emulsions technology from A*STAR’s Institute of Chemical and Engineering Sciences (ICES). By leveraging A*STAR’s research and development capabilities, it is envisioned that this MoU will enable Hyphens to develop innovative and differentiated dermatological products to address unmet market needs.

Hyphens is a Singapore-headquartered ASEAN specialty pharma company. Operating in six countries across the region, Hyphens has a strong medical, regulatory and commercial capability. Dermatology is a key therapeutic focus field where Hyphens markets products under the brands “Ceradan” and “TDF”.

Read more Read less
View more
Go top